Send to a Friend Share

Jefferies Maintains a 'Buy' on Thermo Fisher Scientific (TMO); Q4 Review

February 2, 2012 1:55 PM EST
TMO Hot Sheet
Rating Summary:
    6 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 11 | New: 38
Jefferies maintains a 'Buy' on Thermo Fisher Scientific (NYSE: TMO) price target raised $1 to $59.

Jefferies analyst says, "Post TMO's 4Q11, we are raising 2012 EPS forecast to $4.75 (from $4.70) to account for a lower tax rate (+$0.14), lower share count (+$0.06), and modestly better organic revenue growth outlook (+$0.04), partially offset by adverse FX headwinds (-$0.16) and a slightly weaker core TMO profit margin outlook (- $0.03)."

"The clean 4Q11 organic revenue upside and credible 2012 organic revenue growth outlook satisfy two critical components of rebounding investor sentiment on the shares, in our view."

For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.

Shares of Thermo Fisher Scientific closed at $54.71 yesterday, with a 52 week range of $43.06-$65.86.


Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In


Related Categories

Analyst Comments

Related Entities

Jefferies & Co

Add Your Comment





Follow StreetInsider.com On Twitter